AU8016094A - Method of contraception - Google Patents
Method of contraceptionInfo
- Publication number
- AU8016094A AU8016094A AU80160/94A AU8016094A AU8016094A AU 8016094 A AU8016094 A AU 8016094A AU 80160/94 A AU80160/94 A AU 80160/94A AU 8016094 A AU8016094 A AU 8016094A AU 8016094 A AU8016094 A AU 8016094A
- Authority
- AU
- Australia
- Prior art keywords
- contraception
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
- G01N33/6869—Interleukin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/52—Assays involving cytokines
- G01N2333/54—Interleukins [IL]
- G01N2333/545—IL-1
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/10—Screening for compounds of potential therapeutic value involving cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/36—Gynecology or obstetrics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/36—Gynecology or obstetrics
- G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Reproductive Health (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13607793A | 1993-10-12 | 1993-10-12 | |
| US136077 | 1993-10-12 | ||
| PCT/US1994/011588 WO1995010298A1 (en) | 1993-10-12 | 1994-10-12 | Method of contraception |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU8016094A true AU8016094A (en) | 1995-05-04 |
Family
ID=22471179
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU80160/94A Abandoned AU8016094A (en) | 1993-10-12 | 1994-10-12 | Method of contraception |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU8016094A (en) |
| WO (1) | WO1995010298A1 (en) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5075222A (en) | 1988-05-27 | 1991-12-24 | Synergen, Inc. | Interleukin-1 inhibitors |
| US6858409B1 (en) | 1988-05-27 | 2005-02-22 | Amgen Inc. | Nucleic acids encoding interleukin-1 inhibitors and processes for preparing interleukin-1 inhibitors |
| US6159460A (en) * | 1988-05-27 | 2000-12-12 | Amgen Inc. | Method for treating interleukin-1 mediated diseases |
| EP0904112B1 (en) * | 1996-02-09 | 2009-11-18 | Amgen Inc., | Composition comprising il-1ra as interleukin-1 inhibitor and hyaluronan as controlled release polymer |
| AU748575B2 (en) * | 1996-02-09 | 2002-06-06 | Swedish Orphan Biovitrum Ab (Publ) | Composition comprising interleukin-1 inhibitor and controlled release polymer |
| US6294170B1 (en) | 1997-08-08 | 2001-09-25 | Amgen Inc. | Composition and method for treating inflammatory diseases |
| EP2319929A1 (en) | 1998-12-23 | 2011-05-11 | Genentech, Inc. | IL-1 related polypeptides |
| RU2003125640A (en) * | 2001-02-06 | 2005-03-10 | Мерк Патент ГмбХ (DE) | MODIFIED INTERLEUKIN 1 (1L-1RA) RECEPTOR ANTAGONIST WITH REDUCED IMMUNOGENITY |
| GB0708376D0 (en) | 2007-05-01 | 2007-06-06 | Alligator Bioscience Ab | Novel polypeptides and uses thereof |
| CA2806438C (en) | 2010-07-29 | 2021-04-13 | Eleven Biotherapeutics, Inc. | Chimeric il-1 receptor type i agonists and antagonists |
| KR102236926B1 (en) | 2013-03-13 | 2021-04-06 | 세센 바이오, 아이엔씨. | Chimeric cytokine formulations for ocular delivery |
| MX385372B (en) | 2015-03-23 | 2025-03-18 | Evestra Inc | Novel cytotoxic agents that preferentially target leukemia inhibitory factor (LIF) for the treatment of malignancies and as novel contraceptive agents |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4961436A (en) * | 1987-07-17 | 1990-10-09 | Brigham And Women's Hospital | Contraceptive cervical cap |
| US5116619A (en) * | 1988-08-30 | 1992-05-26 | Lee Roy Morgan | Vaginal progesterone tablet |
-
1994
- 1994-10-12 WO PCT/US1994/011588 patent/WO1995010298A1/en not_active Ceased
- 1994-10-12 AU AU80160/94A patent/AU8016094A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO1995010298A1 (en) | 1995-04-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU4013193A (en) | Method of maintaining relationships between elements | |
| AU7557594A (en) | Method of fertilizer application | |
| AU1322195A (en) | Method of assay | |
| AU7968694A (en) | Bags and method of making bags | |
| AU7700896A (en) | Method of orienting cans | |
| AU4868493A (en) | Method of combining polymers | |
| AU8016094A (en) | Method of contraception | |
| AU6752294A (en) | Preparation process of acrylamide | |
| PL313740A1 (en) | Method of | |
| AU3385693A (en) | Determination method | |
| AU6723294A (en) | Use of simmondsine | |
| AU6368394A (en) | Polymer-polypeptide composition and method | |
| EP0821576A4 (en) | Method of contraception | |
| AU3342093A (en) | Lens and method of making same | |
| AU1197495A (en) | Method for abandonment of subseawells | |
| AU3423693A (en) | Methods of terminating pregnancy | |
| AU7590794A (en) | Method of sealing | |
| AU1287095A (en) | Package and method of making said package | |
| AU1674295A (en) | Preparation of doped polycarbynes | |
| AU3847693A (en) | One-pot process | |
| AU6905994A (en) | Method of mining | |
| AU7131094A (en) | Method of laminate manufacture | |
| AU8099694A (en) | Method of preventing disasters | |
| AU7338294A (en) | Method for endomodification of proteins | |
| RU2003311C1 (en) | Method of blepharorrhaphy |